Both medicines are administered as subcutaneous injections, typically once weekly, and are still undergoing large-scale clinical trials
Possible protective effects on the gastrointestinal system
It directly targets metabolic homeostasis, significantly improving insulin sensitivity and prompting the body to utilize fat for energy
and, as former Director of the Helmholtz Diabetes Center and the Institute for Diabetes and Obesity at Helmholtz Zentrum Mnchen (20112018), and, since 2018, as CEO of Helmholtz Zentrum Mnchen, has been responsible for collaborations with a multitude of companies and institutions worldwide in this capacity, he discussed potential projects with and has signed/signs contracts for his institute(s) and for the staff for research funding and/or collaborations with industry and academia worldwide, including but not limited to pharmaceutical corporations such as Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Medigene, Arbormed, BioSyngen and others